GCIA
GBT

Gabelli & Co Investment Advisers’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-231,506
Closed -$15.8M – 484
2022
Q3 		$15.8M Buy
+231,506
New +$12.8M 2.04% 10

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Gabelli & Co Investment Advisers's GBT Position: Q4 2022 in Review

Gabelli & Co Investment Advisers sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 231,506 shares — an estimated $15.8M sold.

Gabelli & Co Investment Advisers first reported a position in GBT in Q3 2022 and held it in 1 quarter. The position peaked at $15.8M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • Gabelli & Co Investment Advisers reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • Gabelli & Co Investment Advisers sold 231,506 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $15.8M.
  • Gabelli & Co Investment Advisers first reported a position in Global Blood Therapeutics, Inc. in Q3 2022 and held it in 1 quarter.
  • Gabelli & Co Investment Advisers's Global Blood Therapeutics, Inc. position peaked at $15.8M in Q3 2022.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Gabelli & Co Investment Advisers's 13F filing for Q4 2022, filed 13 Feb 2023.